Strides Pharma Science Limited has informed the Exchange about press release dated 21-Feb-2022 titled ���Strides receives USFDA approval for Amantadine Hydrochloride Softgel Capsules���
Press Release Feb 21 2022
Filed with NSE ·
6ix hasn’t read this filing yet.
Strides Pharma Science Ltd on 6ix
Earlier from Strides Pharma Science
- Press Release Jan 20 2022
- Press Release Jan 17 2022
- Press Release Dec 28 2021
- Press Release Aug 06 2021
- Press Release Jun 28 2021
Later from Strides Pharma Science
- Press Release Mar 11 2022
- Extra Ordinary Meeting
- Newspaper Advertisements
- Press Release Mar 17 2022
- Press Release Mar 21 2022
Follow Strides Pharma Science into a list and get an email when it puts out news.
Follow Strides Pharma Science